Sign inJoin waitlistJoin the waitlist

Alyssa Reddy

Program Director · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

University of California (San Francisco) School of Medicine
Present

Child and Adolescent Psychiatry
1999–2001
Child Neurology
University of Alabama at Birmingham Marnix E. Heersink School of Medicine
1996–1999
Pediatrics
University of Alabama at Birmingham Marnix E. Heersink School of Medicine
1993–1996
University of Alabama at Birmingham Marnix E. Heersink School of Medicine
1989–1993

Research

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Journal of Clinical Oncology · 2016 · 699 citations
GFAP mutations, age at onset, and clinical subtypes in Alexander disease
Neurology · 2011 · 211 citations
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
Cancer Cell · 2016 · 210 citations

Arie Perry
12 papers · 5 as a fellow
David Solomon
11 papers
Nalin Gupta
11 papers
Mitchel Berger
10 papers
Melike Pekmezci
9 papers
Susan Chang
9 papers
Andrew Bollen
8 papers · 4 as a fellow
Joanna Phillips
8 papers
Sabine Mueller
8 papers
Tarik Tihan
8 papers
Anuradha Banerjee
7 papers
BH
Ben Ho
7 papers

Clinical trials

Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
Principal investigator · Completed · Phase 3
Children's Oncology Group
2009–2024
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Site PI · Recruiting · Phase 2
Children's Oncology Group
2024–2033
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Site PI · Recruiting · Phase 3
Children's Oncology Group
2023–2029
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2022–2027